Welcome

The Division has pioneered immunosuppression research, having been a leader in the development of cyclosporine, being the first to administer rapamycin to humans in the drug’s clinical trials and to apply a mathematical model to document the synergistic effects of this drug combination, leading to FDA approval.

Please visit the Department of Surgery website.